Business

Announcement on Voluntary Disclosure of the Issuance of Approval Notices for Supplementary Applications for Drugs and Supplementary Applications for Drug Clinical Trials

Announcement on Voluntary Disclosure of the Issuance of Approval Notices for Supplementary Applications for Drugs and Supplementary Applications for Drug Clinical Trials

articleShanghai Micurx Pharmaceutical Co., Ltd. Class ANovember 5, 20255/news/announcement-on-voluntary-disclosure-of-the-issuance-of-approval-notices-for-supplementary-applications-for-drugs-and-supplementary-applications-for-drug-clinical-trials
Announcement on Voluntary Disclosure of the Issuance of Approval Notices for Supplementary Applications for Drugs and Supplementary Applications for Drug Clinical Trials

About this update from Shanghai Micurx Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Issuance of Approval Notices for Supplementary Applications for Drugs and Supplementary Applications for Drug Clinical TrialsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Micurx Pharmaceutical Co., Ltd. Class A